Stuart Poulton - Insider Trading & Ownership

Location
85 Wells Avenue, Newton, MA
Summary
The estimated net worth of Stuart Poulton is at least $441K dollars as of October 16, 2025. Stuart Poulton is the EVP, Chief Development Officer of Karyopharm Therapeutics Inc. and owns shares of Karyopharm Therapeutics Inc. (KPTI) stock worth about $441K.
Signature
/s/ Nancy Smith as Attorney-in-Fact for Stuart Poulton
All Insider Reports
All Insider Reports

Ownership of Stuart Poulton

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
KPTI Karyopharm Therapeutics Inc. EVP, Chief Development Officer $441K -$7.14K -1.59% Oct 15, 2025

Insider Transactions Reported by Stuart Poulton:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.